- Generic name
- Esomeprazole
- Strength
- 40 mg/vial
- Dosage form
- Injection
- Manufactured by
- Biopharma Ltd.
Esocon-40 IV Injection
About Esocon-40 IV Injection
Made by Biopharma Ltd., Esocon-40 IV is a injection whose active ingredient is Esomeprazole. A doctor decides whether it is appropriate for your condition and how long it should be taken.
There are 161 brands of Esomeprazole listed in Bangladesh. The lowest listed price is Emo 20 mg Tablet at ৳ 1 per unit.
What is Esocon-40 IV Injection?
Esocon-40 IV is a injection from Biopharma Ltd., with the generic name Esomeprazole. Esocon-40 IV is a 40 mg/vial injection, a form that can be dispersed in water. This helps relieve chronic heartburn and other symptoms of gastroesophageal reflux disease, allows erosive esophagitis to heal and stay healed, and is used alongside other medicines to clear Helicobacter pylori infection in people with duodenal ulcer disease. Ask your doctor or pharmacist about anything unclear.
Uses of Esocon-40 IV
A doctor decides whether it is appropriate for your condition and how long it should be taken. It is also used together with two antibiotics to eradicate Helicobacter pylori infection in patients with duodenal ulcer disease. It is also used to help heal erosive esophagitis, an inflamed food pipe, and to keep it healed afterwards.
How to use Esocon-40 IV
The doctor sets the dose, how often it is given and how long the course lasts. Do not inject it yourself unless a doctor has shown you how. Esocon-40 IV is given as an injection by a healthcare professional. Take Esocon-40 IV 40 mg/vial injection as your doctor tells you. Complete the course exactly as prescribed. Do not change the dose or stop early without asking your doctor.
Side effects of Esocon-40 IV
If you notice any unusual or severe reaction, seek medical advice promptly. The side effects most often reported with Esomeprazole are headache, diarrhoea, nausea, wind, abdominal pain, constipation and dry mouth. Your doctor can advise on how to manage side effects. Ask your doctor before taking other medicines alongside it. Contact your doctor if you notice any unusual symptoms.
Safety and precautions
There are no adequate studies in pregnant women, and it is not known if Esomeprazole passes into breast milk. Do not receive it if you are allergic to Esomeprazole or any ingredient of the injection; tell the doctor about any allergy first. It is contraindicated in patients with known hypersensitivity. Tell your doctor about all the other medicines you take.
Frequently asked questions
What does Esocon-40 IV treat?
A doctor decides whether it is appropriate for your condition and how long it should be taken. It is also used together with two antibiotics to eradicate Helicobacter pylori infection in patients with duodenal ulcer disease.
How do I use Esocon-40 IV correctly?
The doctor sets the dose, how often it is given and how long the course lasts. Do not inject it yourself unless a doctor has shown you how.
What should I watch for while using Esocon-40 IV?
If you notice any unusual or severe reaction, seek medical advice promptly. The side effects most often reported with Esomeprazole are headache, diarrhoea, nausea, wind, abdominal pain, constipation and dry mouth.
Is Esocon-40 IV safe for everyone?
There are no adequate studies in pregnant women, and it is not known if Esomeprazole passes into breast milk. Do not receive it if you are allergic to Esomeprazole or any ingredient of the injection; tell the doctor about any allergy first.
Indications
- To relieve from chronic heartburn symptoms and other symptoms associated with GERD
- For the healing of erosive esophagitis
- For maintenance of healing of erosive esophagitis
- In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease. ... Read more
- To relieve from chronic heartburn symptoms and other symptoms associated with GERD
- For the healing of erosive esophagitis
- For maintenance of healing of erosive esophagitis
- In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.
- Zollinger-Ellison Syndrome
- Acid related Dyspepsia
- Duodenal & Gastric ulcer
Pharmacology
Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma concentration-time curve (AUC) from 20 to 40 mg. At repeated once daily dosing, the systemic bioavailability is approximately 90% compared to 64% after a single dose. The AUC after administration of a single dose of esomeprazole is decreased by 33-53% after food intake compared to fasting conditions. Esomeprazole should be taken at least one hour before meals.
Distribution: Esomeprazole is 97% bound to plasma proteins. Plasma protein binding is constant over the concentration range of 2 20 mmol/L. The apparent volume of distribution at steady state in healthy volunteers is approximately 16 L.
Metabolism: Esomeprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system. The metabolites of esomeprazole lack anti-secretory activity. The major part of esomeprazole’s metabolism is dependent upon the CYP2C19 isoenzyme, which forms the hydroxy and desmethyl metabolites. The remaining amount is dependent on CYP3A4 which forms the sulphone metabolite.
Excretion: The plasma elimination half-life of esomeprazole is approximately 1–1.5 hours. Less than 1% of parent drug is excreted in the urine. Approximately 80% of an oral dose of esomeprazole is excreted as inactive metabolites in the urine, and the remainder is found as inactive metabolites in the faeces.
Combination Therapy with Antimicrobials: Esomeprazole magnesium 40 mg once daily is given in combination with clarithromycin 500 mg twice daily and amoxicillin 1000 mg twice daily for 7 days. The mean steady state AUC and Cmax of Esomeprazole increased by 70% and 18%, respectively, during triple combination therapy compared to treatment with Esomeprazole alone. The pharmacokinetic parameters for clarithromycin and amoxicillin are similar during triple combination therapy and administration of each drug alone. However, the mean AUC and Cmax for 14-hydroxyclarithromycin are increased by 19% and 22%, respectively, during triple combination therapy compared to treatment with clarithromycin alone. This increase in exposure to 14-hydroxyclarithromycin is not considered to be clinically significant.
Dosage & Administration
Healing of Erosive Esophagitis: 20 mg or 40 mg Once Daily for 4-8 Weeks. The majority of patients are healed within 4 to 8 weeks. For patients who don't heal after 4-8 weeks, an additional 4-8 weeks of treatment may be considered. Maintenance of Healing of Erosive
Esophagitis: 20 mg Once Daily (Clinical studies did not extend 6 months).
Symptomatic GERD: 20 mg Once Daily for 4 Weeks. If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.
Helicobacter Pylori eradication: Triple Therapy to reduce the risk of Duodenal Ulcer recurrence-Esomeprazole 40 mg Once Daily for 10 days, Amoxicillin 1000 mg Twice Daily for 10 days, Clarithromycin 500 mg Twice Daily for 10 days.
Zollinger-Ellison Syndrome: The dose is 20-80 mg once daily. The dosage should be adjusted individually and treatment continued as long as clinically indicated.
Acid-related Dyspepsia: 20-40 mg once daily for 2-4 weeks according to the response.
Duodenal ulcer: 20 mg once daily for 2-4 weeks. Gastric ulcer: 20-40 mg once daily for 4-8 weeks.
Injection: The recommended adult dose is 40 mg Esomeprazole given once daily by intravenous injection (not less than 3 minutes) or intravenous infusion (10 to 30 minutes). Esomeprazole IV injection should not be administered concomitantly with any other medications through the same intravenous site. Treatment with Esomeprazole IV injection should be discontinued as soon as the patient is able to resume treatment with Esomeprazole delayed-release capsules. Safety and effectiveness in paediatric patients have not been established.
Interaction
Esomeprazole may potentially interfere with CYP2C19, the major Esomeprazole metabolizing enzyme. Co-administration of Esomeprazole 30 mg and diazepam, a CYP2C19 substrate has resulted in a 45% decrease in clearance of diazepam. Increased plasma levels of diazepam have been observed 12 hours after dosing and onwards. Esomeprazole inhibits gastric acid secretion. Therefore, Esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ketoconazole, iron salts and digoxin).
Co-administration of oral contraceptives, diazepam, phenytoin, or quinidine do not seem to change the pharmacokinetic profile of Esomeprazole.
Combination Therapy with Clarithromycin: Co-administration of esomeprazole, clarithromycin, and amoxicillin has resulted in increases in the plasma levels of esomeprazole and 14-hydroxyclarithromycin.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Information for patients: Esomeprazole capsules should be taken at least one hour before meals. For patients who have difficulty swallowing capsules, one tablespoon of applesauce can be added to an empty bowl and the Esomeprazole capsules can be opened, and the pellets inside the capsule carefully emptied onto the applesauce. The pellets should be mixed with the applesauce and then swallowed immediately. The applesauce used should not be hot and should be soft enough to be swallowed without chewing. The pellets should not be chewed or crushed. The pellet/applesauce mixture should not be stored for future use. Antacids may be used while taking esomeprazole.
Overdose Effects
Storage Conditions
Alternative brands of Esomeprazole
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.